PegiHepTM
-
Zydus successfully completes phase-2 trial of Pegylated Interferon alpha2b on COVID-19 patients
Ahmedabad-based pharma company Zydus Cadila on Thursday announced successful completion of phase-two clinical trial on COVID-19 patients with its biological…
Read More »